News
Publications
Multimedia
Conferences
Webcasts
Resources
Event Calendar
Subscribe

Spotlight -

Drug Development|

Quality Systems

|Articles|October 11, 2007

FMEA tool

Author(s)Keith Truman, Phil Nethercote, Phil Borman

This downloadable Failure Mode Effect Analysis tool accompanies the article titled 'The Application of Quality by Design to Analytical Methods' by Phil Borman et. al.

External Link - article-464686.xls

Newsletter

Get the essential updates shaping the future of pharma manufacturing and compliance. Subscribe to Pharmaceutical Technology and never miss an industry breakthrough.

Related Content

The Implications of Orzeyful (oveporexton) approval by the FDA

Why the Orzeyful Approval Matters Beyond One Drug Class

ByZachary Zubulake

August 6th 2026

How to Maintain a Productive Sponsor-CMO Relationship

ByDr. Hui-Yin (Harry) Li,Susan Haigney

August 4th 2026

Is Organizational Readiness Pharma's Real AI Barrier in 2026?

H1 2026 in Review: AI Adoption, Onshoring, and Data Gaps

ByZachary Zubulake,Megha Sinha,Manish Garg, PMP, PSM,Remco Munnik,Mike Stenberg,Campbell Bunce,Saharsh Davuluri

August 3rd 2026

Regulatory Roundup—July 2026

BySusan Haigney

July 31st 2026

PharmTech Weekly Roundup—July 31, 2026

BySusan Haigney

July 31st 2026

Trending on Pharmaceutical Technology

What Does Moderna's mRNA Flu Vaccine Approval Signal?

Why the Orzeyful Approval Matters Beyond One Drug Class

How to Maintain a Productive Sponsor-CMO Relationship

What the OSTP’s New Policy Blueprint Means for Pharma Manufacturing and Development

Is Organizational Readiness Pharma's Real AI Barrier in 2026?